Psykey, Inc. (CEOS)
USD 0.01
(-14.81%)
USD 0.01
(-14.81%)
| Year | Total Liabilities | Total Liabilities Growth |
|---|---|---|
| 2023 | 2.47 Million USD | 78.34% |
| 2022 | 1.38 Million USD | 40.34% |
| 2021 | 988.48 Thousand USD | 20536.51% |
| 2020 | 4790.00 USD | -0.01% |
| 2019 | 4790.30 USD | 0.0% |
| 2018 | 4790.30 USD | 0.0% |
| 2016 | 4.53 Million USD | 10.23% |
| 2015 | 4.11 Million USD | 60.08% |
| 2014 | 2.56 Million USD | 0.0% |
| 2007 | 1.4 Million USD | -24.89% |
| 2006 | 1.87 Million USD | 36395.15% |
| 2005 | 5130.00 USD | 0.0% |
| Year | Total Liabilities | Total Liabilities Growth |
|---|---|---|
| 2023 FY | 2.47 Million USD | 78.34% |
| 2023 Q3 | 1.97 Million USD | 15.0% |
| 2023 Q4 | 2.47 Million USD | 25.37% |
| 2023 Q1 | 1.46 Million USD | 5.82% |
| 2023 Q2 | 1.71 Million USD | 16.9% |
| 2022 Q2 | 1.19 Million USD | 11.33% |
| 2022 Q4 | 1.38 Million USD | 7.51% |
| 2022 FY | 1.38 Million USD | 40.34% |
| 2022 Q1 | 1.07 Million USD | 8.38% |
| 2022 Q3 | 1.29 Million USD | 8.18% |
| 2021 Q1 | 66.34 Thousand USD | 0.0% |
| 2021 FY | 988.48 Thousand USD | 20536.51% |
| 2021 Q4 | 988.48 Thousand USD | 52.79% |
| 2021 Q3 | 646.96 Thousand USD | 862.77% |
| 2021 Q2 | 67.19 Thousand USD | 1.28% |
| 2020 FY | 4790.00 USD | -0.01% |
| 2019 FY | 4790.30 USD | 0.0% |
| 2018 FY | 4790.30 USD | 0.0% |
| 2016 FY | 4.53 Million USD | 10.23% |
| 2015 FY | 4.11 Million USD | 60.08% |
| 2014 FY | 2.56 Million USD | 0.0% |
| 2008 Q2 | 1.25 Million USD | -12.18% |
| 2008 Q3 | 407.62 Thousand USD | -67.47% |
| 2008 Q1 | 1.42 Million USD | 1.48% |
| 2007 FY | 1.4 Million USD | -24.89% |
| 2007 Q4 | 1.4 Million USD | 29.88% |
| 2007 Q1 | 1.84 Million USD | -1.67% |
| 2007 Q3 | 1.08 Million USD | -19.31% |
| 2007 Q2 | 1.34 Million USD | -27.11% |
| 2006 Q4 | 1.87 Million USD | -60.47% |
| 2006 Q2 | 934.25 Thousand USD | 37.52% |
| 2006 FY | 1.87 Million USD | 36395.15% |
| 2006 Q1 | 679.34 Thousand USD | 0.0% |
| 2006 Q3 | 4.73 Million USD | 406.95% |
| 2005 FY | 5130.00 USD | 0.0% |
| Name | Total Liabilities | Total Liabilities Difference |
|---|---|---|
| American Medical Technologies Inc. | 2.34 Million USD | -5.284% |
| Ansell Limited | 1.32 Billion USD | 99.814% |
| Ansell Limited | 1.33 Billion USD | 99.814% |
| BG Medicine, Inc. | - USD | -Infinity% |
| Biotage AB (publ) | 126.33 Million USD | 98.042% |
| BioLife Sciences Inc. | - USD | -Infinity% |
| CB Scientific, Inc. | 943.17 Thousand USD | -162.308% |
| ConvaTec Group Plc | 2.01 Billion USD | 99.877% |
| ConvaTec Group Plc | 2.02 Billion USD | 99.878% |
| Encision Inc. | 1.98 Million USD | -24.701% |
| Golden Valley Development, Inc | - USD | -Infinity% |
| Hear AtLast Holdings, Inc. | 3.04 Million USD | 18.631% |
| Innovative MedTech Inc. | 6.13 Million USD | 59.673% |
| LifePoint, Inc. | 2.45 Million USD | -0.809% |
| Medite Cancer Diagnostics, Inc. | 10.18 Million USD | 75.7% |
| Paradigm Medical Industries, Inc. | 3.4 Million USD | 27.235% |
| QuantRx Biomedical Corporation | - USD | -Infinity% |
| Remedent, Inc. | 3.04 Million USD | 18.626% |
| Reflect Scientific, Inc. | 776.32 Thousand USD | -218.682% |
| SmileDirectClub, Inc. | 982.26 Million USD | 99.748% |
| Sector 10, Inc. | 9.84 Million USD | 74.871% |
| Shandong Weigao Group Medical Polymer Company Limited | 1.35 Billion USD | 99.818% |
| SheerVision, Inc. | 1.43 Million USD | -72.839% |
| United Health Products, Inc. | 1.99 Million USD | -23.771% |
| Vasamed, Inc. | 1 Million USD | -146.098% |
| Wearable Health Solutions, Inc. | 3.8 Million USD | 34.899% |
| Yubo International Biotech Limited | 2.91 Million USD | 15.097% |